JPRN-UMIN000002481已完成4 期
Investigation of efficacy and safety of lanthanum carbonate in hyperphosphatemia patients treated with cinacalcet hydrochloride - Investigation of efficacy and safety of lanthanum carbonate in hyperphosphatemia patients treated with cinacalcet hydrochloride
Shigei medical research hospital0 个研究点目标入组 10 人开始时间: 2009年9月11日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Pts who meet the contraindiation criteria in package insert of lanthanum carbonate 2)Pregnant or possibly pregnant pts, pts on lactation 3)Inappropriate pts for this study according to the investigator's judgment
研究者
相似试验
已完成
4 期
Evaluation of efficacy and safety of lanthanum carbonate in hyperphosphatemia patients on dialysis with either 2.5 or 3.0 mEq/L of dialysate calcium concentratioMaintenance hemodialysis patients with hyperphosphatemiaJPRN-UMIN000002820Rakuwakai Otowa Kinen Hospital200
已完成
不适用
A Clinical Trial to study the Safety and Efficacy of Litemeds pain Management Device in Subjects with musculoskeletal PaiCTRI/2022/07/043775itemed India Private Limited240
进行中（未招募）
不适用
A phase ii study of the efficacy and safety of lenalidomide combined to escalating doses of chemotherapy in intermediate-2-or high risk MDS and AML with del 5 q31 - GFM-chimio-Rev-08Myelodysplastic Syndrome(MDS) / Acute Myeloid Leukemia(AML)MedDRA version: 9.1Level: LLTClassification code 10028533Term: Myelodysplastic syndromeEUCTR2008-006032-36-FRGroupe Francophone des Myélodysplasies (GFM)
尚未招募
3 期
A study to evaluate the role of laxatives in childhood foreign body ingestioCTRI/2024/03/064508Bangalore Medical College and Research Institute
进行中（未招募）
1 期
A phase II study of the efficacy and safety of lenalidomide combined to azacitidine in intermediate-2 or high risk MDS AND AML with del 5q - GFM-Aza-Rev-09Myelodysplastic Syndrome(MDS) / Acute Myeloid Leukemia(AML)MedDRA version: 9.1Level: LLTClassification code 10028533Term: Myelodysplastic syndromeEUCTR2009-011160-11-FRGroupe Francophone des Myélodysplasies (GFM)